Effect of rivastigmine on mobility of patients with higher-level gait disorder: A pilot exploratory study

Drugs in R and D

Volumn 14, Issue 2, 2014, Pages 57-62

  Gurevich, Tanya ^a,b   Balash, Yacov ^a,b   Merims, Doron ^c   Peretz, Chava ^b   Herman, Talia ^a   Hausdorff, Jeffrey M ^a,b,d   Giladi, Nir ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Shoham Geriatric Medical Center   (Israel)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIVASTIGMINE; CARBAMIC ACID DERIVATIVE; NEUROPROTECTIVE AGENT;

AGED; ANXIETY; ARTICLE; BALANCE DISORDER; BLURRED VISION; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG DOSE ESCALATION; DRUG EFFECT; FATIGUE; FEMALE; GAIT DISORDER; GERIATRIC DEPRESSION SCALE; HIGHER LEVEL GAIT DISORDER; HUMAN; LOW DRUG DOSE; MALE; MEMORY; MENTAL PERFORMANCE; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; NAUSEA; PARKINSONISM; PHYSICAL MOBILITY; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATE TRAIT ANXIETY INVENTORY; TREATMENT DURATION; VERTIGO; WEAKNESS; GAIT DISORDERS, NEUROLOGIC; ORAL DRUG ADMINISTRATION; VERY ELDERLY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; NEUROPROTECTIVE AGENTS; PHENYLCARBAMATES; PILOT PROJECTS;

EID: 84904360497     PISSN: 11745886     EISSN: 11796901     Source Type: Journal    
DOI: 10.1007/s40268-014-0038-8     Document Type: Article

References (40)

1. Sudarsky L. Geriatrics: gait disorders in the elderly. N Engl J Med. 1990;322:1441-6. (Pubitemid 20152530)
2. Nutt JG, Marsden CD, Thompson PD. Human walking and higher-level gait disorders, particularly in the elderly. Neurology. 1993;43:268-79. (Pubitemid 23060255)
3. Herman T, Giladi N, Gurevich T, Hausdorff JM. Gait instability and fractal dynamics of older adults with a "cautious" gait: why do certain older adults walk fearfully? Gait Posture. 2005;21:178-85. (Pubitemid 41556837)
4. Peretz C, Herman T, Hausdorff JM, Giladi N. Assessing fear of falling: can a short version of the Activities-specific Balance Confidence scale be useful? Mov Disord. 2006;21:2101.
5. Huber-Mahlin V, Giladi N, Herman T, Perez C, Gurevich T, Hausdorff JM. Progressive nature of a higher level gait disorder: a 3-year prospective study. J Neurol. 2010;257:1279-86.
6. Yogev-Seligmann G, Hausdorff JM, Giladi N. The role of executive function and attention in gait. Mov Disord. 2008;23:329-42.
7. Hausdorff JM, Yogev G, Springer S, Simon ES, Giladi N. Walking is more like catching than tapping: gait in the elderly as a complex cognitive task. Exp Brain Res. 2005;164:541-8. (Pubitemid 41073774)
8. Assal F, Allali G, Kressig RW, Herrmann FR, Beauchet O. Galantamine improves gait performance in patients with Alzheimer's disease. J Am Geriatr Soc. 2008;56:946-7. (Pubitemid 351652394)
9. Montero-Odasso M, Wells J, Borrie M. Can cognitive enhancers reduce the risk of falls in people with dementia? An open-label study with controls. J Am Geriatr Soc. 2009;57:359-60.
10. Chung KA, Lobb BM, Nutt JG, Horak FB. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology. 2010;75:1263-9.
11. Montero-Odasso M, Wells JL, Borrie MJ, Speechley M. Can cognitive enhancers reduce the risk of falls in older people with mild cognitive impairment? A protocol for a randomised controlled double blind trial. BMC Neurol. 2009;9:42.
12. Henderson EJ, Lord SR, Jacqueline CT, Close JCT, Lawrence AD, Whone E, Ben-Shlomo Y. The ReSPonD trial: rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen. BMC Neurol. 2013;13:188.
13. Cummings JL. Cholinesterase inhibitors: a new class of psychotropic compounds. Am J Psychiatry. 2000;157(1):4-15. (Pubitemid 30027415)
14. Nutt JG, Horak FB, Bloem BR. Milestones in gait, balance, and falling. Mov Disord. 2011;26:1166-74.
15. Chastan N, Do MC, Bonneville F, Torny F, Bloch F, Westby GW, et al. Gait and balance disorders in Parkinson's disease: impaired active braking of the fall of centre of gravity. Mov Disord. 2009;24:188-95.
16. Snijders AH, Leunissen I, Bakker M, Overeem S, Helmich RC, Bloem BR, Toni I. Gait-related cerebral alterations in patients with Parkinson's disease with freezing of gait. Brain. 2011;134:59-72.
17. Karachi C, Grabli D, Bernard FA, Tandé D, Wattiez N, Belaid H. Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Investig. 2010;120:2745-54.
18. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-98.
19. Shiekh J, Yesavage J. Geriatric Depression Scale: recent findings and development of a short version Clinical Gerontology: a guide to assessment and intervention. New York: Howard Press; 1986.
20. Powell LE, Myers AM. The Activities-specific Balance Confidence (ABC) scale. J Gerontol A Biol Sci Med Sci. 1995;50A:M28-34.
21. Spielberger CD, Gorsuch RL, Kushene RP, Vagg R, Jacobs GA. State-trait anxiety inventory: self-evaluation questionnaire (form y) In: Spielberger CD, editor. Manual for the State-Trait Anxiety Inventory. Palo Alto: Consulting Psychologist Press; 1983
22. Dwolatzky T, Whitehead V, Doniger GM, Simon ES, Schweiger A, Jaffe D, et al. Validity of the Mindstreams computerized cognitive battery for mild cognitive impairment. J Mol Neurosci. 2004;24:33-44. (Pubitemid 41359165)
23. Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142-8.
24. Okumiya K, Matsubayashi K, Nakamura T, Fujisawa M, Osaki Y, Doi Y, et al. The timed "up & go" test is a useful predictor of falls in community-dwelling older people. J Am Geriatr Soc. 1998;46:928-30. (Pubitemid 28328516)
25. Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go test. Phys Ther. 2000;80:896-903.
26. Hausdorff JM, Nelson ME, Kaliton D, Layne JE, Bernstein MJ, Nuernberger A, et al. Etiology and modification of gait instability in older adults: a randomized controlled trial of exercise. J Appl Physiol. 2001;90:2117-29. (Pubitemid 32467403)
27. Hausdorff JM, Rios DA, Edelberg HK. Gait variability and fall risk in community-living older adults: a 1-year prospective study. Arch Phys Med Rehabil. 2001;82:1050-6. (Pubitemid 32744331)
28. Frenkel-Toledo S, Giladi N, Peretz C, Herman T, Gruendlinger L, Hausdorff JM. Treadmill walking as an external pacemaker to improve gait rhythm and stability in Parkinson's disease. Mov Disord. 2005;20:1109-14. (Pubitemid 41632196)
29. Giladi N, Huber-Mahlin V, Herman T, Hausdorff JM. Freezing of gait in older adults with high level gait disorders: association with impaired executive function. J Neural Transm. 2007;114:1349-53. (Pubitemid 47498120)
30. Buchman AS, Boyle PA, Leurgans SE, Barnes LL, Bennett DA. Cognitive function is associated with the development of mobility impairments in community-dwelling elders. Am J Geriatr Psychiatry. 2011;19:571-80.
31. Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ, Buschke H. Abnormality of gait as a predictor of non-Alzheimer's dementia. N Engl J Med. 2002;347:1761-8. (Pubitemid 35375615)
32. Gauthier S, Juby A, Dalziel W, Réhel B, Schecter R. EXPLORE investigators. Effects of rivastigmine on common symptomatology of Alzheimer's disease. Curr Med Res Opin. 2010;26:1149-60.
33. Weiss A, Herman T, Plotnik M, Brozgol M, Giladi N, Hausdorff JM. An instrumented timed up and go: the added value of an accelerometer for identifying fall risk in idiopathic fallers. Physiol Meas. 2011;32:2003-18.
34. Herman T, Giladi N, Hausdorff JM. Properties of the 'timed up and go' test: more than meets the eye. Gerontology. 2011;57:203-10.
35. Nordin E, Lindelöf N, Rosendahl E, Jensen J, Lundin-Olsson L. Prognostic validity of the Timed Up-and-Go test, a modified Get-Up-and-Go test, staff's global judgement and fall history in evaluating fall risk in residential care. Age Ageing. 2008;37:442-8. (Pubitemid 351965890)
36. Mirelman A, Herman T, Brozgol M, Dorfman M, Sprecher E, Schweiger A, et al. Executive function and falls in older adults: new findings from a five-year prospective study link fall risk to cognition. PLoS One. 2012;7:e40297.
37. Donoghue OA, Horgan NF, Savva GM, Cronin H, O'Regan C, Kenny RA. Association between timed up-and-go and memory, executive function, and processing speed. J Am Geriatr Soc. 2012;60:1681-6.
38. Giladi N, Shabtai H, Gurevich T, Benbunan B, Anca M, Korczyn AD. Rivastigmine (Exelon) for dementia in patients with Parkinson's disease. Acta Neurol Scand. 2003;108:368-73. (Pubitemid 37357643)
39. Schmitt FA, Farlow MR, Meng X, Tekin S, Olin JT. Efficacy of rivastigmine on executive function in patients with Parkinson's disease dementia. CNS Neurosci Ther. 2010;16:330-6.
40. Kurz A, Farlow M, Lefèvre G. Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review. Int J Clin Pract. 2009;63:799-805.